Dr. Lal Path Labs Ltd. — Dividend/Bonus, 24-07-2026: Dividend

Dr. Lal PathLabs has announced a Board meeting outcome, approving the financial results for the quarter ended June 30, 2026. For shareholders, an Interim Dividend of ₹5 per equity share for FY26-27 has been declared, with a record date of July 30, 2026, and payment within 30 days. Additionally, the company approved granting stock options to eligible employees and noted subsidiary acquisitions: Sunshine Healthcare (Ghana) for up to ₹38 Cr (80% stake) and Neuome Technologies (India) for up to ₹3.5 Cr (30% stake).